| Product NDC: | 0009-3169 |
| Proprietary Name: | PROSTIN |
| Non Proprietary Name: | alprostadil |
| Active Ingredient(s): | 500 ug/mL & nbsp; alprostadil |
| Administration Route(s): | INTRAVASCULAR; INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0009-3169 |
| Labeler Name: | Pharmacia and Upjohn Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA018484 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19811016 |
| Package NDC: | 0009-3169-06 |
| Package Description: | 5 AMPULE in 1 PACKAGE (0009-3169-06) > 1 mL in 1 AMPULE (0009-3169-01) |
| NDC Code | 0009-3169-06 |
| Proprietary Name | PROSTIN |
| Package Description | 5 AMPULE in 1 PACKAGE (0009-3169-06) > 1 mL in 1 AMPULE (0009-3169-01) |
| Product NDC | 0009-3169 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | alprostadil |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVASCULAR; INTRAVENOUS |
| Start Marketing Date | 19811016 |
| Marketing Category Name | NDA |
| Labeler Name | Pharmacia and Upjohn Company |
| Substance Name | ALPROSTADIL |
| Strength Number | 500 |
| Strength Unit | ug/mL |
| Pharmaceutical Classes | Genitourinary Arterial Vasodilation [PE],Prostaglandin Analog [EPC],Prostaglandin E1 Agonist [EPC],Prostaglandin Receptor Agonists [MoA],Prostaglandins [Chemical/Ingredient],Venous Vasodilation [PE] |